Related references
Note: Only part of the references are listed.A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers
Z. Q. Ling et al.
ANNALS OF ONCOLOGY (2014)
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms
Karthika Natarajan et al.
BIOCHEMICAL PHARMACOLOGY (2013)
RUNX family: Regulation and diversification of roles through interacting proteins
Linda Shyue Huey Chuang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro
Riccardo Adamo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
Jun Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest
Guilin Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors
Marjo Malinen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients
Yong-hai Peng et al.
PLOS ONE (2013)
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Ulrike Weirauch et al.
NEOPLASIA (2013)
Adenoid Cystic Carcinoma: Clinical and Molecular Features
Christopher A. Moskaluk
HEAD & NECK PATHOLOGY (2013)
Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma
Qingshan Yang et al.
BLOOD (2012)
Expressions of osteopontin (OPN), ανI23 and Pim-1 associated with poor prognosis in non-small cell lung cancer (NSCLC)
Yi Jin et al.
CHINESE JOURNAL OF CANCER RESEARCH (2012)
Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
Benedict Yan et al.
GASTRIC CANCER (2012)
Molecular biology of adenoid cystic carcinoma
Jia Liu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells
Xiao-Fen Lai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
The PIM kinases in hematological cancers
Yesid Alvarado et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
Lisa S. Chen et al.
BLOOD (2011)
TGF-β1 Promotes Migration and Invasion of Salivary Adenoid Cystic Carcinoma
L. Dong et al.
JOURNAL OF DENTAL RESEARCH (2011)
Adenoid cystic carcinoma: A rare clinical entity and literature review
Shailesh M. Gondivkar et al.
ORAL ONCOLOGY (2011)
For better or for worse: the role of Pim oncogenes in tumorigenesis
Martijn C. Nawijn et al.
NATURE REVIEWS CANCER (2011)
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
Jongchan Kim et al.
BMC CANCER (2010)
Why target PIM1 for cancer diagnosis and treatment?
Nancy S. Magnuson et al.
FUTURE ONCOLOGY (2010)
Expression of RUNX3 in salivary adenoid cystic carcinoma: Implications for tumor progression and prognosis
Jian-Feng He et al.
CANCER SCIENCE (2008)
Pim-1 Kinase Phosphorylates and Stabilizes RUNX3 and Alters Its Subcellular Localization
Hye-Ryun Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity
Teija L. T. Aho et al.
BMC CELL BIOLOGY (2006)
Share Paper
